Skip to main content

Imvexxy News

Major Women's Health Study Supports Hormone Replacement Therapy in Early Menopause

WEDNESDAY, May 1, 2024 – Hormone replacement therapy can safely ease middle-aged women’s symptoms during early menopause, data from a major women’s health study show. Women younger than 60 can use ho...

Oral Contraceptives May Protect Against Rheumatoid Arthritis

WEDNESDAY, Nov. 8, 2023 – Oral contraceptive use appears to protect against rheumatoid arthritis (RA), while menopausal hormone therapy (MHT) use may increase the risk for late-onset RA, according...

TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause

BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Atrophic Vaginitis

Imvexxy patient information at Drugs.com